-
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapyApproval represents the first indication in the U.S. for TEVIMBRA
-
Global Atlantic Financial Group (“Global Atlantic”), a leading insurance company meeting the retirement and life insurance needs of individuals and institutions, today announced the launch of the Global Atlantic Re foundation in Bermuda, which has been seeded with $1 million dedicated to the promotion of economic development, education and environmental sustainability initiatives throughout the island.This press release features multimedia. View the full release here: https://www.businesswire.co
-
Hub Brings Together Producers, End-Users, World-Class Technology Experts, and Necessary Infrastructure to Advance the Production, Use, and Delivery of Hydrogen in Appalachia
-
Program is first in nation to cover lost wages for any living donor supporting an employee